Retatrutide

Clinical Trials

Retatrutide (LY3437943)

Aliases
LY3437943, Triple-G
Administration
Subcutaneous injection (once weekly)

Sources

Every source cited on the Retatrutide pages. Each link points to the record itself, so you can check what it says.